EXPRESSIONS OF INTEREST ARE NOW CLOSED
In June this year, PCFA launched a new three-year $4.5 million Priority Impact Research Award, the Ignite Synergy Grant (PIRA-ISG).
The grant aims to ignite prostate cancer discoveries in Australia while empowering the country’s next generation of research leaders, and supporting high-impact scientific advancement with the potential for near-term clinical translation.
The initiative brings together leading scientists, clinicians, and institutions in a coordinated effort to accelerate progress against prostate cancer.
This competitive grant will be funded by PCFA’s Future Fund, which was established in 2022 to accelerate our work towards zero deaths from prostate cancer in our lifetime.
Important dates:
|
Expressions of Interest open |
Monday June 30 2025 |
|
EOI submission deadline |
5pm Friday August 8 2025 |
|
EOI outcome announced, short-listed applicants invited to submit full application |
Thursday September 11 2025 |
|
Full application submission deadline |
5pm Thursday October 30 2025 |
|
Expert Panel review of full applications and deliberations |
Monday November 3 – Monday November 24 2025 |
|
Short-listed applicant interviews (by Zoom) |
Tuesday December 2 – Friday December 5 2025 |
|
Short-listed applicants advised of outcome (under embargo until award announcement) |
December 2025 |
|
Anticipated Award Notification |
January 2026 |
|
Funding Start Date - flexible |
Available from January 1 2026 - Negotiable, within six (6) months of accepting the award |
For more information, please contact:
Ms Hannah Lunnay
Governance and Research Executive
Prostate Cancer Foundation of Australia
Via email to research@pcfa.org.au
